Skip to main content
search

Gorlin Syndrome

Hightower’s previous clinical study focused on improving care for Gorlin syndrome by aiming to prevent recurring basal cell carcinomas and promote long-term skin health.

                       

Hightower’s Efforts in Basal Cell Carcinoma Prevention

Gorlin syndrome, or nevoid basal cell carcinoma syndrome, is a genetic condition that affects multiple parts of the body and increases the risk of both cancerous and noncancerous tumors. The most common cancer seen in this condition is basal cell carcinoma, a type of skin cancer that often begins to appear in adolescence or early adulthood.

To support patients with Gorlin syndrome, Hightower Clinical conducted a study to evaluate the safety and effectiveness of a topical treatment aimed at preventing new basal cell carcinomas from developing on the face of affected adults.

Past Study Focused on Preventing Facial Tumors in Gorlin Syndrome

Hightower Clinical conducted a study to support individuals with Gorlin syndrome by evaluating the safety and effectiveness of a topical treatment to prevent new facial basal cell carcinomas. This effort aimed to improve long-term skin health and reduce the recurrence of skin cancer in affected adults.

Current Status

Not Recruiting

Study Count

01

Study Information

Gorlin Syndrome

Study NameProtocol NumberSponsor
Gorlin Syndrome

SGT610-01

Sol-Gel Technologies

Frequently Asked Questions

1. What was the purpose of the Gorlin syndrome clinical study?

The study aimed to prevent new basal cell carcinomas on the face and assess the safety of a topical treatment for adults with Gorlin syndrome.

2. Who participated in the study?

Adults diagnosed with Gorlin syndrome who were at risk of developing facial basal cell carcinomas.

3. Is the study currently open for enrollment?

No, the study is not recruiting at this time.

Close Menu